Phase 3 Spasticity Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity
Upper Limb Spasticity
Chongqing Claruvis Pharmaceutical Co., Ltd.300 enrolled16 locationsNCT07478822
Recruiting
Phase 2Phase 3
A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults
Upper Limb Spasticity
Chongqing Claruvis Pharmaceutical Co., Ltd.254 enrolled24 locationsNCT06783114
Recruiting
Phase 2Phase 3
Therapeutic Photobiomodulation and Tretament of Spasticity
Muscle SpasticityCerebral PalsyPhotobiomodulation+1 more
University of Nove de Julho28 enrolled2 locationsNCT06536751
Not Yet Recruiting
Phase 3
The proposed study will answer the key question whether Botulinum toxin injection in the spastic (tight) lower limb muscles following stroke improves walking and the quality of life.
Lower limb spasticityPost stroke lower limb spasticityStroke+1 more
The Hospital Research Foundation80 enrolled1 locationACTRN12617001603303
Active
Phase 3
The effect of botulinum toxin-A on the functional ability of the very young child with spastic hemiplegia due to cerebral palsy.
spasticity in children with cerebral palsy
Sarah Love30 enrolled1 locationACTRN12607000484448